Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease

Evaluation of the Impact of Care Based on Sensory Support for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease

The main objective of this study is to evaluate the effect of 3 months of "Snoezelen-type" multi-sensory care sessions on NeuroPsychiatric Inventory Questionnaire (NPI-Q) scores for patients with Alzheimer's-type neurodegenerative disease.

The secondary objectives of this study are to study the following elements in relationship to the implementation of a "Snoezelen-type" multi-sensory care strategy for patients with Alzheimer's-type neurodegenerative disease:

A. to evaluate the effects on NPI-Q scores at 1 month, 6 months and 12 months .

B. evaluate the effects on quality of life (questionnaire QOL-AD) at 0 and 12 months.

C. assess changes in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire over 0, 1, 3, 6 and 12 months.

D. assess changes in drug consumption (anxiolytics, antidepressants, hypnotics, neuroleptics)over the study period

Inclusion Criteria:

• The patient's legal representative must have given his/her informed and signed consent (or the patient if he/she is judged competent)
• The patient must be insured or beneficiary of a health insurance plan
• Alzheimer's-type neurodegenerative pathology
• The patient has been living in the participating center for > 2 months

Exclusion Criteria:

• The patient's legal representative refuses to sign the consent (or the patient if he/she is judged competent)
• It is impossible to correctly inform the patient's legal representative
• The patient has already has Snoezelen-therapy